Cell Line Development Services

Download our slides to find out more about our cell line development services and the Cellca CHO Expression Platform.

Sartorius Stedim Biotech Launches Chemistry Testing Services

Goettingen, GER | Glasgow, UK – May 4, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, announced the launch of a full range of chemistry testing services. Offered by its subsidiary BioOutsource, they characterize the physicochemical properties and structural attributes of therapeutic monoclonal antibodies (mAbs). The service platform methods have More

Sartorius Stedim BioOutsource Scoop Life Science Company of the Year Award

On Wednesday 19th April 2017, Sartorius Stedim BioOutsource was named as Scottish Life Sciences Company of the Year at the Made in Scotland awards. The annual Made in Scotland awards rewards Scottish companies that have innovative products and services and have subsequently found success domestically and internationally. We were delighted to be announced as the winner More

Biosimilars: Lessons Learned

A Quality by Design approach to de-risk biosimilar development Biosimilar drugs have become a mainstay of modern medicine with the latest reports stating the global market could reach $55 billion by 2020. The ever evolving landscape has led to different approaches to biosimilar development over the years. Many sponsors now prefer a linear, orthogonal approach More

Is ADCC the biggest challenge to your biosimilar?

It’s not as easy as ADCC…Avoid costly pitfalls during the development of your biosimilar by accurately determining ADCC activity. Watch our video to learn how ADCC assays can help unpick the issues of similarity between innovator and biosimilar drugs.

Expansion of Sartorius Stedim Cellca

• Biopharma provider purchases property in Science Park III of Ulm • Laboratory and office facility to be constructed on the site by 2019 Göttingen/Laupheim, December 14, 2016 – Sartorius Stedim Cellca based near Ulm in southern Germany, continues on the growth track. At the end of November, the company in its eleventh year since More

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.